Lu-177 FAP-2286
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lu-177 FAP-2286, covering 2026-02-25 to 2026-02-25. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary [Phase 2]